Stocks drifted higher on Wall Street in midday trading Thursday, as gains in tech companies and retailers helped boost the market. The S&P 500 rose less than 0.1%. The benchmark index is coming off a three-day winning streak. The Dow Jones Industrial Average was up 19 points, or 0.1%, as of 12:32 p.m. Eastern time. The Nasdaq composite was up less than 0.1%. Trading volume was lighter than usual as U.S. markets reopened after the Christmas holiday. Chip company Broadcom rose 2.9%, Intel was up 0.7% and Apple gained 0.4%. While tech stocks overall were in the green, some heavyweights were a drag on the market. Semiconductor giant Nvidia, whose enormous valuation gives it an outsize influence on indexes, slipped 0.2%. Meta Platforms fell 0.9%, Amazon was down 0.5%, and Netflix gave up 1.4%. Health care stocks also helped lift the market. CVS Health rose 1.9% and Walgreens Boots Alliance rose 3.3% for the biggest gain among S&P 500 stocks. Several retailers also gained ground. Target rose 2.9%, Best Buy was up 2.1% and Dollar Tree gained 2.2%. U.S.-listed shares in Honda and Nissan rose 4.1% and 15.8%, respectively. The Japanese automakers announced earlier this week that the two companies are in talks to combine. Traders got a labor market update. U.S. applications for unemployment benefits held steady last week , though continuing claims rose to the highest level in three years, the Labor Department reported. Treasury yields rose in the bond market. The yield on the 10-year Treasury rose to 4.61% from 4.59% late Tuesday. Major European markets were closed, as well as Hong Kong, Australia, New Zealand and Indonesia. Trading was expected to be subdued this week with a thin slate of economic data on the calendar. Still, U.S. markets have historically gotten a boost at year’s end despite lower trading volumes. The last five trading days of each year, plus the first two in the new year, have brought an average gain of 1.3% since 1950. So far this month, the U.S. stock market has lost some of its gains since President-elect Donald Trump’s win on Election Day, which raised hopes for faster economic growth and more lax regulations that would boost corporate profits. Worries have risen that Trump’s preference for tariffs and other policies could lead to higher inflation , a bigger U.S. government debt and difficulties for global trade. Even so, the U.S. market remains on pace to deliver strong returns for 2024. The benchmark S&P 500 is up roughly 26% so far this year and remains near its most recent all-time high it set earlier this month — its latest of 57 record highs this year. Wall Street has several economic reports to look forward to next week, including updates on pending home sales and home prices, a report on U.S. construction spending and snapshots of manufacturing activity. AP Business Writers Elaine Kurtenbach and Matt Ott contributed.
Iowa cornerback Jermari Harris has opted out of the remainder of the 2024 season in order to prepare for the NFL draft, according to a report by 247Sports.com . The 6-foot-1 sixth-year senior from Chicago has recorded 27 tackles, three interceptions and a team-high seven pass breakups in 10 games for the Hawkeyes this season. That includes a pick-6 in a 38-21 win over Troy earlier this season. Iowa (6-4, 4-3 Big Ten) plays at Maryland on Saturday before closing out its regular season at home against Nebraska on Nov. 29. The Hawkeyes are already bowl eligible, so Harris is likely opting out of three games in total. After missing the entire 2022 season due to an ankle injury, Harris was suspended for two games of the following season for his involvement in the gambling investigation into Iowa athletics. He later emerged as the Hawkeyes' top cornerback, earning the team's comeback player of the year award after compiling 42 tackles, one interception and eight pass breakups. Harris will finish his college career with 105 tackles and eight interceptions. --Field Level MediaNone
Search the Stow n' Go or the Cup Holder! Chrysler Pacifica and The Elf on the Shelf Create Holiday Magic This Season
NoneWHEN is actually the best time to suspend classes? The Department of Education’s (DepEd) Order 37 serves as the basis for automatic class suspensions, tied to storm signal warnings issued by the Philippine Atmospheric, Geophysical, and Astronomical Services Administration (Pagasa). For instance, classes in all levels are only canceled automatically in areas under Signal No. 3. The order also indicates that local government heads can announce class suspensions based on local conditions, a decentralized approach that allows flexibility. Pagasa’s current system issues warnings with varying durations depending on the severity of the storm; the lead time decreases as the signal number increases. Signal No. 1, for example, allows up to 36 hours of lead time before the expected onslaught of a storm. For Ricarido Saturay, a science high-school teacher, the lead time is not always indicative of an immediate threat, as wind impacts may not be felt for hours. As such, suspending classes too early may result in missed learning days. Saturay majored in geology for both his bachelor’s and master’s degrees, and holds a PhD in data science. “The 36 hours, it’s such a long time, but it’s good to be prepared ahead,” he told BusinessMirror in a mix of English and Filipino. “But as I was thinking, how long does it take for you to send your kids back to their homes? You could have one or two days [of class] that you will miss ... you still won’t [really] experience that wind threat in 36 hours.” The last academic year lost a total of 55 teaching days, according to the government think tank Philippine Institute for Development Studies (PIDS), due to typhoons, conflict, and school celebrations, among others. Karol Mark Yee, executive director of the Second Congressional Commission on Education, lamented that the whopping number of disruptions provided “very limited time” for students to “absorb the lessons.” Emphasizing the need to effectively communicate lead time to the public, Saturay expressed a belief that DO 37 could still be enforced while suggesting that automatic class suspensions should not be declared immediately upon raising a storm signal. “There can still be an automatic suspension but they shouldn’t say automatic suspension immediately upon raising,” he said. “Maybe give it 12 hours or 24 hours after the signal number is raised, then it can still be an automatic suspension.” The teacher’s advice to DepEd? “In consultation with Pagasa, they should set the appropriate time for suspension.” Amend DO 37? On November 20, an education undersecretary said that his principal, Secretary Sonny Angara, vowed that DO 37 would be amended to ensure the balance between students’ safety and the need for uninterrupted learning. “His instruction was that by next week, we should report our draft amendments to DO 37,” Undersecretary for governance and field operations Revsee Escobedo said in a radio interview. “What Secretary Angara wants is to have a balance between prioritizing the safety and welfare of our teachers and learners, but on the other hand, ensure that the class suspensions are reasonable and would not further exacerbate the learning crisis that we are currently in,” he added. Pagasa side THE lead time, while helpful, is not always sufficient to fully prepare for the storm, especially in terms of the amount of rainfall that can arrive even before the wind does, according to Pagasa Zamboanga officer-in-charge Rodel Inclan. “In those short periods, there are a lot of things that can happen,” he said during a hydrometeorological risk reduction forum on November 22. “The signal number given is only for the strength of the wind. But the rain, most likely, is already in that area.” Inclan said it’s better to be prepared before it’s too late. “It’s not exactly 36 hours,” he said. “So at least we can prepare and take care of our kids.” He added that whether earlier class suspensions are recommended depends on the specific conditions of each area. “There are some places where they have a signal number, but they don’t flood, they don’t have an open area, or the effect is less on them,” Inclan stressed. Still, he clarified that the decision to cancel classes—whether in-person, online or both—ultimately lies within the purview of the DepEd and local government units (LGUs). “In our agency, we provide the scenario and the information, but the ultimate decision is taken by DepEd. They are the deciding factor,” the Pagasa officer said. “What we do is that we give them the information, and based on that information, they are going to create or they are going to have the decision-making.” Solidum: Lead time for preps Department of Science and Technology Secretary Renato Solidum emphasized that the lead time has more to do with preparations. “The wind signals have a lead time before the effect is felt. This is to provide early warning for preparedness,” he told the BusinessMirror in a Viber message. He added, “Hence what can be reviewed are the SOPs [standard operating procedures] by DepEd, LGU and NDRRMC [National Disaster Risk Reduction and Management Council] based on warning. But rainfall is another consideration and rainfall warning information is also available.” In an email to the BusinessMirror, Pagasa advocated a rationalized approach to class suspensions by prioritizing safety while minimizing disruptions to education. “Much of the disruptive nature of suspension in relation to wind signal was brought about by the recent changes in the automatic class suspension guidelines...without due consideration of the lead time or the level of potential impacts from winds,” said Robb Gile, a senior weather specialist. “To ensure a balance between safety and educational continuity, TCWS [tropical cyclone wind signal] can be used as basis for automatic suspension of classes by considering...the lead time available based on the time of hoisting of a signal level,” he added. The agency also suggested involving predisaster risk assessment (PDRA) meetings to guide suspension decisions. “A possible way forward which may be considered is to base the suspension decision on the result of the PDRA meeting undertaken by the NDRRMC, regional DRRM councils, and local DRRM offices.”Ancelotti says Bellingham is 'fine' after Real Madrid midfielder substituted with apparent leg issue
Member of iconic 70s rock band shocks fans by announcing his ‘last show’
Thanksgiving is my favorite American holiday. Let me count some of the ways I love Thanksgiving: Because it isn’t very commercialized. Because it doesn’t leave out the lovelorn and the lonely. Because it has an intrinsic honesty: It’s about being grateful. Because it’s about as much extended family as most of us can take: just one day of them. Because the political class generally shuts up. It doesn’t feel necessary to make long atavistic speeches with dubious grandiloquence that no one believes, least of all the speakers. Because you don’t have to receive presents and lie to your close friends and family, “I always wanted a toy pig that burps,” or “Thank you for the lovely necktie. I’m sure they will come back into fashion in a few decades.” Because no flags or bunting appear, and most houses aren’t turned into glaring neon performance art, nor are skeletons hanging from swing sets. Because you don’t have to wear a funny hat and red or green or any other color that signals that you are in the spirit of the event. Because when I worked on the newspapers, I could volunteer and get paid double or better in overtime for a shift on Thanksgiving Day. From my arrival at New York’s Idlewild Airport in 1963, I have been able to luxuriate in America’s bounty and give thanks. It wasn’t always easy being an immigrant, even one of favored language and provenance (British), and it didn’t spare me and my English wife, Doreen, from hard times. We had those. But America remained the mansion on the high ground where, if we were lucky, we could be let in to enjoy the riches of acceptance. My first experience of the United States — and I give thanks for it — was the taxi driver who, when he learned I had hardly any money, gave me a free guided tour of Manhattan, Bronx and Brooklyn. Finally, he deposited me at an uncompromising address on Flatbush Avenue in Brooklyn, where I was to stay while I found work and before I sent for Doreen, my cherished first wife. It was a walk-up with no air conditioning. My hosts were an English couple in their 70s: Doreen’s aunt and her husband. She helped with newborns in wealthier people’s homes well into her old age. He had worked rather unsuccessfully as an industrial jeweler. They were palpably short of money and hadn’t enjoyed an easy life since arriving in America in 1918. Their story had a fairytale, extraordinary last volume. Out on Long Island, their grandson and granddaughter were growing up with a single mother, also in straitened circumstances. She worked with seedlings in a plant nursery. The grandson was to climb to the apex of achievement, to stun his family and, in time, the world with his talent. This young man and I would swim in Long Island Sound, where we would head for anchored yachts with people partying on board. A decade older than my companion, I always believed that when they looked down on the swimmers, the partiers would invite us aboard for food and drink. It never happened, but we enjoyed our aquatic adventures and social failure. If they had only known! As I said, that young man was destined to win all that his mother and grandparents didn’t have. His name is Billy Joel, the “Piano Man.” He is someone for all in America to be thankful for — proof that in the United States, the last can be first. King is the executive producer and host of “White House Chronicle” on PBS. He wrote this for InsideSources.com . Get local news delivered to your inbox!Removing a splinter? Treating a wart? If a doctor does it, it can be billed as surgery
Officials celebrate substantial completion of new Gilcrease Museum buildingTHE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced the closing of its previously announced underwritten public offering of common stock units and pre-funded warrant units for aggregate gross proceeds of approximately $10.0 million, prior to deducting underwriting discounts and commissions and offering expenses, which amount includes the partial exercise of the over-allotment option granted to the underwriter. The equity offering was comprised of 615,500 common stock units (which included 156,809 common stock units issued upon exercise of the underwriter's over-allotment option) and 917,596 pre-funded warrant units, priced at a public offering price of $6.54 per common stock unit and $6.539 per pre-funded warrant unit. Each common stock unit and pre-funded warrant unit consisted of one share of common stock (or, in lieu of common stock, a pre-funded warrant to purchase one share of common stock at an exercise price of $0.001) and one warrant to purchase one share of common stock that expires on the five-year anniversary of the date of issuance (a "Series A Warrant"). The exercise price for the Series A Warrant is $6.54 per share. The warrants issued in this transaction were fixed priced and do not contain any variable pricing features. The securities comprising the units were immediately separable and were issued separately. Ladenburg Thalmann & Co. Inc. acted as the sole bookrunning manager for the offering. The Company intends to use the net proceeds from this offering to fund its clinical trial, for other research and development, for development of intellectual property, and for working capital. The securities described above were offered by the Company pursuant to a registration statement on Form S-1 (No. 333-282940), which was declared effective by the Securities and Exchange Commission (the "SEC”) on November 22, 2024. The offering was made solely by means of a prospectus. A final prospectus relating to and describing the terms of the offering was filed with the SEC on November 25, 2024 and is available on the SEC's website at http://www.sec.gov. Electronic copies of the final prospectus may be obtained from Ladenburg Thalmann & Co. Inc., 640 Fifth Avenue, 4th Floor, New York, New York 10019, or by telephone at (212) 409-2000, or by email at [email protected] . This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. Forward Looking Statements Some of the statements in this release are "forward-looking statements,” which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation the use of the anticipated proceeds from the offering. Such forward-looking statements can be identified by the use of words such as "should,” "might,” "may,” "intends,” "anticipates,” "believes,” "estimates,” "projects,” "forecasts,” "expects,” "plans,” and "proposes.” Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors” and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission ("SEC”) on May 31, 2024, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law. Investor and Media Contact JTC Team, LLC Jenene Thomas 908-824-0775 [email protected]
NASHVILLE, Tenn. (AP) — Brian Callahan insisted Monday he's busy preparing to coach the Tennessee Titans against the Jacksonville Jaguars, not what controlling owner Amy Adams Strunk thinks of his first season. “It’s a bottom line business and we’ve got to show progress and we haven’t shown enough,” Callahan said. “I would like to see more and we got two more opportunities to do it." The Titans have lost four straight after a 38-30 defeat in Indianapolis , dropping the season series to their AFC South foe. They also have lost six of seven to drop to 3-12, putting the franchise two losses from matching the most in a season set in 2014 when the NFL played a 16-game schedule. Asked if he thinks he will have to make a case to keep his job when this season ends, Callahan said he has no idea. “My job is to coach the football team and get ready to go play Jacksonville,” Callahan said. “That’s the only thing that I focus on. And anything other than that, is out of my control.” What’s working The Titans played a season-high 10 rookies in Indianapolis. Even with all that youth, they were flagged only four times matching their second-lowest total of the season. That was a huge improvement from the week before when Tennessee was penalized 12 times for 110 yards. What needs help Callahan said every time they try to fix one thing, another issue pops up. Against Indianapolis, the run defense simply disappeared . They gave up 335 yards rushing, the most in franchise history since Oct. 1, 1961. They gave up touchdown runs of 65 and 70 yards to Jonathan Taylor. A defense that entered Week 16 ranked 12th allowed Taylor to average 7.5 yards per carry and meant Anthony Richardson needed to throw just 11 passes. The Titans gave up 38 consecutive points — the third most allowed in a game all season just a week after giving up 37 in a loss to Cincinnati. Stock up TE Chig Okonkwo. He led the Titans with nine catches and 81 yards receiving — both career highs. He also scored his the second 2-point conversion of his career. He became the first tight end with nine or more receptions in a game since Delanie Walker had nine Nov. 13, 2016, against Green Bay. Stock down Mason Rudolph. Callahan defended the veteran's three interceptions with one going off running back Tony Pollard's hands and the third a last-gasp play to end the game and said he thought Rudolph had a good performance. That said, Rudolph's numbers are almost a mirror image of the quarterback he replaced. Rudolph has eight touchdown passes and eight interceptions. He's completing 63.8% of his passes and has a 78.8 passer rating. That's nearly the same as Will Levis completing 63.7% of his passes with 12 TD passes and 12 interceptions. Callahan said turnovers from the quarterback spot has sort of been “our Achilles' heel” swinging games. But he also hasn't made a decision yet on who starts Sunday, saying stats don't always paint the full picture. “My goal is to try to put the best chance to win on the field for us and we’ll see what that looks like,” Callahan said. Injuries Callahan said K Nick Folk might have a chance to be back after an abdominal injury sidelined the veteran in Indianapolis. The Titans are practicing with a walk-through Tuesday and taking Wednesday off for Christmas so the coach said he'll have a better handle on injuries Thursday. But Folk's replacement Brayden Narveson missed a 53-yard field goal that would have given Tennessee a 10-0 lead. The Titans waived Narveson on Monday afternoon. They also activated Jaelyn Duncan, hurt four snaps into his lone start at right tackle in a loss to Buffalo on Oct. 20, from injured reserve. Key num ber 121 — Number of points allowed off turnovers this season. It's the most in a season for the Titans since at least 2000, topping the 108 given up in 2015. The Titans lead the NFL with 32 turnovers, which Callahan called their biggest issue. “That’s insanity,” Callahan said. Next steps The Titans visit Jacksonville on Sunday for their final road trip, trying to avoid being swept by their division rival. Then it's back home for the regular-season finale, hosting Houston before more changes this offseason in some form. ___ AP NFL: https://apnews.com/hub/nfl Teresa M. Walker, The Associated Press
Spotlight on Carl Medearis: Pioneering Sustainable Real Estate Development in Colorado 12-10-2024 12:04 AM CET | Industry, Real Estate & Construction Press release from: Getnews / PR Agency: Erase Technologies, LLC Image: https://www.getnews.info/wp-content/uploads/2024/12/1733758473.jpg Carl Medearis, Colorado. Real estate developer and visionary, Carl Medearis, has been featured in a comprehensive new business-focused interview that delves deep into his impactful career in real estate across Colorado. Known for his innovative approach to development, Carl's work emphasizes sustainability and community engagement, setting a new standard for the industry. Throughout his decades-long career, Carl has been instrumental in identifying underutilized properties and transforming them into vibrant, eco-friendly communities. His approach combines advanced technology with sustainable practices, ensuring each project not only meets but enhances the quality of life for its residents. In the interview, Carl shares insights into his journey from a young enthusiast fascinated by architecture and land to a leading real estate developer. He discusses his method for identifying potential development sites, emphasizing the importance of sustainability, community needs, accessibility, and unique property features that can be preserved or enhanced. Carl also reflects on one of his most challenging projects - the redevelopment of an old mining site which required innovative environmental solutions and close community cooperation to transform into a thriving residential area. This project, like many others, highlights his commitment to responsible development and his belief in working with, not just in, the community. As the industry evolves, Carl notes a significant shift towards integrating smart technology in homes and buildings, which has reshaped living spaces and operational efficiencies. Looking forward, he anticipates further growth in mixed-use developments and adaptive reuse of buildings, advocating for a balance between economic viability and environmental and social responsibilities. For young entrepreneurs aspiring to enter the real estate development sector, Carl advises a thorough understanding of urban planning, market trends, and environmental impacts. He underscores the importance of creativity, integrity, and building strong industry relationships. Reflecting on his career, Carl wishes he had embraced risk earlier, acknowledging that some of his most successful projects were also the most daunting initially. His journey is a testament to the power of stepping out of one's comfort zone and the impact of visionary thinking in real estate development. To read the full interview, visit the website here [ https://ceoworld.biz/ ]. About Carl Medearis: Carl Medearis is an expert real estate developer and investor based in Elizabeth, Colorado. He is a graduate of the University of Colorado in Colorado Springs, where he earned degrees in History and Education. Carl is dedicated to developing sustainable, community-focused real estate projects that enhance local environments and economies. His commitment to ethical practices and community betterment continues to inspire new generations of developers. Media Contact Contact Person: Carl Medearis Email: Send Email [ http://www.universalpressrelease.com/?pr=spotlight-on-carl-medearis-pioneering-sustainable-real-estate-development-in-colorado ] City: Elizabeth State: Colorado Country: United States Website: https://www.carlmedeariscolorado.com/ This release was published on openPR.Prez confers Pradhan Mantri Rashtriya Bal Puraskar on 17 children for excellence in various fieldsWASHINGTON — After decades of inaction, federal transportation officials have moved ahead with requiring new technologies to reduce crashes and fatalities involving large trucks. But the incoming administration could install a red light to block their efforts. At issue are proposed new rules by the Federal Motor Carrier Safety Administration and the National Highway Traffic Safety Administration to require large trucks to be equipped with automatic emergency braking systems and devices to limit their speeds. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get the latest news, sports, weather and more delivered right to your inbox.
NEW YORK (AP) — U.S. stocks rose Monday, with those benefiting the most from lower interest rates and a stronger economy leading the way. The S&P 500 climbed 0.3% to pull closer to its all-time high set two weeks ago. The Dow Jones Industrial Average added 440 points, or 1%, to its own record set on Friday, while the Nasdaq composite rose 0.3%. Treasury yields also eased in the bond market amid what some analysts called a “Bessent bounce” after President-elect Donald Trump said he wants Scott Bessent , a hedge fund manager, to be his Treasury Secretary. Bessent has argued for reducing the U.S. government’s deficit, which is how much more it spends than it takes in through taxes and other revenue. Such an approach could soothe worries on Wall Street that Trump’s policies may lead to a much bigger deficit, which in turn would put upward pressure on Treasury yields. After climbing above 4.44% immediately after Trump’s election, the yield on the 10-year Treasury fell back to 4.26% Monday, down from 4.41% late Friday. That’s a notable move, and lower yields make it cheaper for all kinds of companies and households to borrow money. They also give a boost to prices for stocks and other investments. That helped stocks of smaller companies lead the way, and the Russell 2000 index of smaller stocks jumped 1.5%. It finished just shy of its all-time high, which was set three years ago. Smaller companies can feel bigger boosts from lower borrowing costs because of the need for many to borrow to grow. The two-year Treasury yield, which more closely tracks the market’s expectations for what the Federal Reserve will do with overnight interest rates, also eased sharply. The Fed began cutting its main interest rate just a couple months ago from a two-decade high, hoping to keep the job market humming after bringing inflation nearly all the way down to its 2% target. But immediately after Trump’s victory, traders had reduced bets for how many cuts the Fed may deliver next year. They were worried Trump’s preference for lower tax rates and higher spending on the border would balloon the national debt. A report coming on Wednesday could influence how much the Fed may cut rates. Economists expect it to show that an underlying inflation trend the Fed prefers to use accelerated to 2.8% last month from 2.7% in September. Higher inflation would make the Fed more reluctant to cut rates as deeply or as quickly as it would otherwise. Goldman Sachs economist David Mericle expects that to slow by the end of next year to 2.4%, but he said inflation would be even lower if not for expected tariff increases on imports from China and autos favored by Trump. In the stock market, Bath & Body Works jumped 16.5% after delivering stronger profit for the latest quarter than analysts expected. The seller of personal care products and home fragrances also raised its financial forecasts for the full year, even though it still sees a “volatile retail environment” and a shorter holiday shopping season this year. Much focus has been on how resilient U.S. shoppers can remain, given high prices across the economy and still-high interest rates. Last week, two major retailers sent mixed messages. Target tumbled after giving a dour forecast for the holiday shopping season. It followed Walmart , which gave a much more encouraging outlook. Another big retailer, Macy’s, said Monday its sales for the latest quarter were in line with its expectations, but it will delay the release of its full financial results. It found a single employee had intentionally hid up to $154 million in delivery expenses, and it needs more time to complete its investigation. Macy’s stock fell 2.2%. Among the market’s leaders were several companies related to the housing industry. Monday’s drop in Treasury yields could translate into easier mortgage rates, which could spur activity for housing. Builders FirstSource, a supplier or building materials, rose 5.9%. Homebuilders, D.R. Horton, PulteGroup and Lennar all rose at least 5.6%. All told, the S&P 500 rose 18.03 points to 5,987.37. The Dow Jones Industrial Average jumped 440.06 to 44,736.57, and the Nasdaq composite gained 51.18 to 19,054.84. In stock markets abroad, indexes moved modestly across much of Europe after finishing mixed in Asia. In the crypto market, bitcoin was trading below $95,000 after threatening to hit $100,000 late last week for the first time. AP Business Writer Elaine Kurtenbach contributed.
Oppenheimer star Emma Dumont comes out as trans masculine non-binary and shares new name
Cynthia Erivo, Demi Moore, Colman Domingo, Jeremy Strong and more react to Golden Globe nominationsNEW YORK--(BUSINESS WIRE)--Nov 25, 2024-- Athena Technology Acquisition Corp. II (NYSE American: ATEK.U, ATEK, ATEK WS) (“ATEK” or the “Company”) received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards due to the failure to timely file the Company’s Form 10-Q for the quarter ended September 30, 2024 (the “Delinquent Report”) by the filing due date of November 19, 2024 (the “Filing Delinquency”). The Company intends to file the Delinquent Report in the near future, however, there is currently no anticipated date for when such Filing Delinquency will be cured via the filing of the Delinquent Report. The Company expects, however, to regain compliance with the NYSE American continued listing standards once the Delinquent Report has been filed. In the interim, the NYSE American Notice has no immediate effect on the listing or trading of the Company’s Class A common stock listed on NYSE American. There can be no assurance that the Company will ultimately regain and remain in compliance with all applicable NYSE American listing standards. Athena Technology Acquisition Corp. II (NYSE American: ATEK.U, ATEK, ATEK WS), incorporated in Delaware, is a special purpose acquisition company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. ATEK is the third SPAC founded by Isabelle Freidheim, who also serves as its Chief Executive Officer, with Kirthiga Reddy as President and Jennifer Calabrese as Chief Financial Officer. Certain statements made in this press release are not historical facts but may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended, and the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” “intend,” or continue or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements are based on the current expectations of the Company’s management and are not predictions of actual performance. Such statements may include, but are not limited to, statements regarding the Company’s plan to file the Delinquent Report within the provided cure period to regain compliance with the NYSE American continued listing standards. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These statements are subject to a number of risks and uncertainties, and actual results may differ materially. These risks and uncertainties include, but are not limited to: the Company’s ability to file the Delinquent Report within the Initial Cure Period to regain compliance with the NYSE American continued listing standards; general economic, political and business conditions; the number of redemption requests made by the Company’s stockholders in connection with a potential business combination; the outcome of any legal proceedings that may be instituted against the Company; the risk that the approval of the Company’s stockholders for a potential transaction is not obtained; expectations related to the terms and timing of a potential business combination; failure to realize the anticipated benefits of a business combination; the risk that a business combination may not be completed by the Company’s business combination deadline and the potential failure to obtain an extension of its business combination deadline in the Company’s upcoming Annual Meeting of Stockholders; costs related to a business combination; and other risks that will be detailed from time to time in filings with the SEC, including those risks discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on September 27, 2024 and in subsequently filed Quarterly Reports on Form 10-Q. The foregoing list of risk factors is not exhaustive. There may be additional risks that could also cause actual results to differ from those contained in these forward-looking statements. In addition, forward-looking statements provide the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. And while the Company may elect to update these forward-looking statements in the future, the Company specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. Nothing herein should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that the results of such forward-looking statements will be achieved. View source version on : CONTACT: Bevel PR KEYWORD: UNITED STATES NORTH AMERICA NEW YORK INDUSTRY KEYWORD: BANKING PROFESSIONAL SERVICES FINANCE SOURCE: Athena Technology Acquisition Corp. II Copyright Business Wire 2024. PUB: 11/25/2024 04:05 PM/DISC: 11/25/2024 04:05 PMLast week, Zack Rosenblatt, Dianna Russini and Michael Silver of The Athletic dropped a bombshell exposé on the New York Jets and team owner Woody Johnson, outlining the various examples of dysfunction within the organization. That report included a number of details about the increasing involvement of Johnson's teenage sons, Brick and Jack, within the organization. The pair reportedly are invited to meetings in team facilities; send articles to their father regarding the team that are believed to influence his decision-making process by some within the organization; are allowed into the locker room on game days (and allowed to invite friends); and Brick even presented a game ball to Garrett Wilson after an October win before quarterback Aaron Rodgers could present one to interim head coach Jeff Ulbrich after his first win upon taking over for the fired Robert Saleh. With that report making the rounds, Rodgers joked on Monday during his weekly appearance on The Pat McAfee Show that he wouldn't be upset if he was released this offseason by Brick Johnson: "I've never been released before, so being released would be a first. Being released by a teenager, that would also be a first," he said. "Hey, you know, I'm open to everything, and I find the comedy in all of it. If that happens, it's a great story." It wouldn't be surprising if the Jets cut ties with Rodgers, namely because he would be due a $35 million option for 2025 and would carry a dead cap charge of $63 million into the 2026 season. Cutting him this offseason, meanwhile, would carry a dead cap charge of $49 million, which they likely would spread out over two seasons by making him a post-June 1 designation—$14 million in 2025 and $35 million in 2026. Expensive, no doubt, but less restrictive than what they'd be facing in 2026 by keeping him around. It will ultimately depend on when, exactly, Brick Johnson is comfortable absorbing the dead cap charge.Fighting TB in multi-pronged manner with new drugs, use of tech: PM Modi
Syrian government services come to a 'complete halt' as state workers stay home after rebel takeoverHAYWARD, Calif.--(BUSINESS WIRE)--Dec 23, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field AblationTM (nano-PFA or nsPFATM) technology, today announced that it intends to deliver an irrevocable notice of redemption, on or about December 27, 2024, to redeem the first tranche of common stock warrants, redeemable by the Company if the Company’s stock trading price exceeds $16.50 for twenty consecutive trading days, that were issued as part of its July 3, 2024 rights offering which are still outstanding as of February 5, 2025 (the “Redemption Date”). These outstanding common stock warrants (the “150% Warrants”), which were issued in the Company’s 2024 rights offering (the “Rights Offering”), pursuant to the Company’s Registration Statement on Form S-3, as amended (File No. 333-278494), may be exercised by the holders thereof until 6:30 p.m., Eastern time, on the Redemption Date, at the exercise price of $11.00 per share of Company common stock, $0.001 par value per share. Any 150% Warrants not exercised before 6:30 p.m., Eastern time, on February 5, 2025, will be redeemed by the Company for $0.01 per 150% Warrant share (the “Redemption Price”). Under the terms of the 150% Warrants, the Company has the right to redeem the 150% Warrants (CUSIP # 74587B135) if the volume weighted average price (as defined therein, “VWAP”) exceeds $16.50 per share for twenty (20) consecutive trading days at least three months after the date that the 150% Warrants were issued. This requirement was met for each of the twenty consecutive trading days preceding December 23, 2024. Over this period, the Company had an average VWAP of $18.85. Any 150% Warrants that remain unexercised at 6:30 p.m., Eastern time, on the Redemption Date, will be void and no longer exercisable, and the holders of those 150% Warrants will be entitled to receive only the Redemption Price of $0.01 per 150% Warrant share. The second tranche of common stock warrants issued in the Rights Offering (the “200% Warrants”) are not being redeemed at this time. The Company received aggregate gross proceeds of $60 million from its Rights Offering, which was completed in July 2024, and the Company will receive an additional $66 million of gross proceeds, if all of the 150% Warrants and all of the 200% Warrants (collectively, the “Warrants”) are exercised prior to the Redemption Date. None of the Company, its board of directors or employees has made or is making any representation or recommendation to any holder of any Warrants as to whether to exercise or refrain from exercising any Warrants. A registration statement, as amended, relating to the Rights Offering was previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective on May 31, 2024. A prospectus relating to the offering was filed with the SEC on and supplemented on June 4, 2024 and is available on the SEC’s website. The Company will post a copy of the notice of redemption being sent to the holders of the 150% Warrants on its investor relations website at investors.pulsebiosciences.com . Questions concerning redemption and exercise of the 150% Warrants can be directed to Broadridge Corporate Issuer Solutions, LLC, Attn: BCIS Re-Organization Dept., P.O. Box 1317, Brentwood, NY 11717-0718, telephone number 888-789-8409 or to shareholder@broadridge.com . No Offer or Solicitation This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFATM technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Pulse Biosciences is now headquartered in Miami, Florida and maintains its office in Hayward, California. Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries. Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s planned redemption of outstanding warrants, statements concerning its expected product development efforts, statements about its Nanosecond Pulsed Field Ablation (nsPFA) technology to non-thermally clear cells while sparing adjacent noncellular tissue, as well as statements concerning customer adoption and future use of the CellFX System to address a range of conditions such as atrial fibrillation. These statements are not historical facts but rather are based on Pulse Biosciences’ current expectations, estimates, and projections regarding Pulse Biosciences’ business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences’ control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences’ filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241223275716/en/ CONTACT: Investor Contacts: Pulse Biosciences Darrin Uecker, CTO or Kevin Danahy, CCO IR@pulsebiosciences.com or Gilmartin Group Philip Trip Taylor 415.937.5406 philip@gilmartinir.com KEYWORD: CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES HEALTH PHARMACEUTICAL CARDIOLOGY SOURCE: Pulse Biosciences, Inc. Copyright Business Wire 2024. PUB: 12/23/2024 04:30 PM/DISC: 12/23/2024 04:30 PM http://www.businesswire.com/news/home/20241223275716/en